Biotech news continually updated from thousands of sources around the net.
3 hrs ago | Reuters
A Novo Nordisk drug combining its long-acting insulin degludec with its type 2 diabetes treatment Victoza has been recommended for approval in Europe, in an important boost for the Danish company.
7 hrs ago | NewsOK.com
Drugmaker AbbVie Inc.'s second-quarter profit increased nearly 3 percent and beat analysts' expectations, as sales soared for the world's top-selling drug, Humira.
10 hrs ago | WTAE-TV Pittsburgh
A lab crucial to diagnosing cases of drug-resistant tuberculosis at the Centers for Disease Control and Prevention has reopened, according to the CDC.
12 hrs ago | KRMG-AM Tulsa
Unacceptably low numbers of teens are getting vaccinated for the human papillomavirus, or HPV, which protects against cervical, throat and mouth cancers, according to the Centers for Disease Control and Prevention.
Bristol-Myers Squibb Co. will create a Redwood City research hub for drugs that stimulate the immune system to fight cancer.
Nearly five years after Congress passed a law enabling future approval of biosimilars, for the first time the FDA has accepted an application to sell a similar, but not identical, version of a biologic drug.
Eli Lilly and Co. on Thursday reported profit that declined by 39 percent in its second quarter, and beat analysts' expectations.
Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.
A U.S. lawmaker will pressure the U.S. Securities and Exchange Commission on Thursday to consider a raft of reforms, after William Ackman's aggressive efforts to take over Allergan Inc raised concerns about loose rules governing disclosure and shareholder voting.
Puma Biotechnology' stock soared Wednesday after the company reported positive trial results for its breast cancer drug, positioning the company as a potential takeover target.
Gilead Sciences' $1,000-a-day hepatitis C pill is facing a firestorm of criticism from insurers and lawmakers, but none of those obstacles are likely to stop the Foster City company from reporting blockbuster revenues during the second quarter today.
The head of the government lab which potentially exposed workers to live anthrax has resigned, an agency spokesman said Wednesday.
Biotechnology stocks were among the biggest gainers. KEEPING SCORE: The Dow Jones industrial average fell 10 points, or 0.1 percent, to 17,104 as of 11:21 a.m. Eastern.
Drug maker GlaxoSmithKline has cut its full-year earnings expectations as it says its second-quarter profits were hit by currency moves and a fall in sales of its respiratory drugs.
The Village of Saranac Lake's plan to grow a cluster of biotechnology companies suffered a setback Monday.
The corrected release reads:... )--Great Lakes Dredge & Dock Corporation , the largest provider of dredging services in the United States and a major provider of env... )--Morgan Stanley will host a Fixed Income Investor conference call on Friday, August 1, 2014 at 9:00 a.m. with Ruth Porat - Executive Vice President and Chie... )--Essensa, a ... (more)
Updated: Fri Jul 25, 2014 02:53 pm
Copyright © 2014 Topix LLC